ATE356208T1 - Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein - Google Patents

Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein

Info

Publication number
ATE356208T1
ATE356208T1 AT01925421T AT01925421T ATE356208T1 AT E356208 T1 ATE356208 T1 AT E356208T1 AT 01925421 T AT01925421 T AT 01925421T AT 01925421 T AT01925421 T AT 01925421T AT E356208 T1 ATE356208 T1 AT E356208T1
Authority
AT
Austria
Prior art keywords
receptor
protein
regulation
lipoxin
human lipoxin
Prior art date
Application number
AT01925421T
Other languages
English (en)
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of ATE356208T1 publication Critical patent/ATE356208T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01925421T 2000-03-14 2001-03-12 Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein ATE356208T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18903700P 2000-03-14 2000-03-14

Publications (1)

Publication Number Publication Date
ATE356208T1 true ATE356208T1 (de) 2007-03-15

Family

ID=22695650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925421T ATE356208T1 (de) 2000-03-14 2001-03-12 Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein

Country Status (7)

Country Link
US (1) US20020058259A1 (de)
EP (1) EP1266005B1 (de)
AT (1) ATE356208T1 (de)
AU (1) AU2001252181A1 (de)
DE (1) DE60127102T2 (de)
ES (1) ES2283403T3 (de)
WO (1) WO2001068839A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2388865A1 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
US20040038862A1 (en) * 2001-07-30 2004-02-26 Goodwin Bryan James Identification of new therapeutic targets for modulating bile acid synthesis
GB0119928D0 (en) * 2001-08-15 2001-10-10 Pfizer Ltd New use
US20060057577A1 (en) * 2002-03-22 2006-03-16 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2
EP1492552A2 (de) * 2002-04-03 2005-01-05 Bayer Aktiengesellschaft Diagnostika and therapeutika für krankheiten, die mit dem "n-formyl peptide receptor like 1 (fprl1)" assoziiert sind
US20060014147A1 (en) * 2002-05-02 2006-01-19 Stefan Golz Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
WO2012135032A2 (en) * 2011-03-25 2012-10-04 The Brigham And Women's Hospital, Inc. Anti-inflammatory particles
EP2597160B1 (de) 2011-11-23 2015-09-23 Universita' Degli Studi "G. d'Annunzio" Chieti-Pescara Untersuchungsinstrument für die Entdeckung von entzündungshemmenden Arzneimitteln mit einem FPR2/ALX-Gen-Promoter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022131A2 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors
WO2000026339A2 (en) * 1998-11-03 2000-05-11 Smithkline Beecham Corporation Axor14, a g-protein coupled receptor
DK1133559T3 (da) * 1998-11-20 2006-04-10 Arena Pharm Inc Human-G-protein-koblet orphan receptor RUP3
DE19930512A1 (de) * 1999-07-05 2001-01-11 Michael Brues NFORMYL: gen, cDNA, Expression und Aminosäuresequenz
GB9924960D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
CA2388865A1 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
EP1235860A2 (de) * 1999-12-10 2002-09-04 Incyte Genomics, Inc. G-protein gekoppelte rezeptoren

Also Published As

Publication number Publication date
WO2001068839A2 (en) 2001-09-20
US20020058259A1 (en) 2002-05-16
DE60127102D1 (de) 2007-04-19
WO2001068839A9 (en) 2002-07-18
WO2001068839A3 (en) 2002-03-28
EP1266005A2 (de) 2002-12-18
DE60127102T2 (de) 2007-08-23
AU2001252181A1 (en) 2001-09-24
EP1266005B1 (de) 2007-03-07
ES2283403T3 (es) 2007-11-01

Similar Documents

Publication Publication Date Title
DE60322339D1 (de) Bindungsproteine als biosensoren
WO2004034988A3 (en) Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors
EA201000245A1 (ru) Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf
EA200700118A1 (ru) Амидосоединения и их применение в качестве лекарственных средств
NO20043245L (no) Bindingsproteiner som biosensorer
MA33402B1 (fr) Compositions et procédés de ciblage de la proteine c3b de complément par des anticorps
ATE497783T1 (de) Gerinnungsfaktor vii-fc chimäre proteine zur behandlung von hämostatischen krankheiten
NZ592973A (en) Compositions and methods of using angiopoietin-like 4 protein
NZ594514A (en) Interleukin-17 BINDING PROTEINS
HUP0301877A2 (hu) Aromatáz inhibitorok és monoklonális anti-HER2 ellenanyagok mint tumorellenes szerek
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
DE60127102D1 (de) Regulation des menschliches lipoxin a4 rezeptor-ähnliches protein
DE60313434D1 (de) Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen
DE60216281D1 (de) Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen
DE60215648D1 (de) Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
BRPI0514124A (pt) anticorpos monoclonais humanos contra a il-4 humana
ATE346147T1 (de) Zusammensetzungen und methoden zur wundheilung
ATE295724T1 (de) Der duale inhibitor der cholesterylester und wachsester synthese avasimibe zur behandlung von erkrankungen des talgdrüse
WO2001042431A3 (en) Regulation of human mitochondrial deformylase
ATE320255T1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen
ATE305041T1 (de) Kompositionen und verwendungen von cgi-69
WO2002000853A3 (en) Regulation of human caspase-1-like protease
WO2001072334A3 (en) Methods for treating disease with antibodies to cxcr3
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización
DE50214750D1 (de) Kinase inhibitoren und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties